MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

Boston BioBreak
Philly BioBreak
BIO Europe BioBreak
New Jersey BioBreak
Utah BioBreak
UK BioBreak
Big BIO BioBreak
Canada BioBreak
New York BioBreak
JPMorgan BioBreak
Sweden BioBreak
All Regions
Yes No
I agree with BioBreak's Privacy Policy

Refer a Friend

Reset Password

JPMorgan BioBreak – Events Archive

Please see below for attendees and images from this event.

JPMorgan JPMorgan BioBreak January 6, 2019 5:30-8:00 pm

Co-Hosts for this event

Name Company
(No co-hosts found)

Attendees at this event

Geoff Meyerson Locust Walk
Mahmoud Mahmoudian Sumitomo Pharma
Jamil Beg 5AM Ventures
Scott Shandler Longevity Biotech
Shawn Bridy Inovio Pharmaceuticals, Inc.
Warren Cooper HealthCare Royalty Partners
Rajeev Dadoo SR One
Keith Goldan Optinose
Deborah Harland SR One
Gary Kurtzman Safeguard
Dean Miller Novitas Capital
Jay Mohr Dirigo Therapeutics
Richard Morris Context Therapeutics
Steven Nichtberger ControlRad Systems
Rifat Pamukcu Midway Pharmaceuticals
H Joseph Reiser Mito Biopharm
Michael Saporito Intervir
Kevin Taylor Nabriva Therapeutics
Marie Lindner Novartis
Harry Atkins Incyte Corporation
Kathleen McGowan Palvella Therapeutics, Inc.
Brian McVeigh Zafgen
Todd Wallach Evogen
Matt Handel ExpressCells
Sarabjit Ashta Glycadia Pharma
Art Fratamico Galera Therapeutics
Jordan Leef Pyramid Biosciences Inc
Joan Lau Militia Hill Ventures
Rachel Cervantes Synthetic Genomics
Terri Sebree Zynerba Pharmaceuticals
Scott Megaffin Adastra Pharam (formerly Tragara)
Alexey Melishchuk Drexel Tech Transfer
Eric Rugart ZSX Medical
Patrick Dougherty WindMIL Therapeutics
Jeremy Goldberg JPG Healthcare LLC
Morgan Conn CallisBio
Ambaw Bellete Photocure Inc.
George Elston 2X Oncology, Inc.
Donald Fishbein Evolve Therapeutics
Sadhana Chitale NYU
Daniel Kennedy Achillion
Douglas Hicks Travecta Therapeutics
Rich Christie Chiasm Foundation
Ira Wallace Mid-Atlantic Bio Angels
Tauseef Butt Progenra
Keith Marmer University of Utah
Jeff Behrens Siamab Therapeutics
Ted Hibben Cerevance
Brian Gallagher Abingworth
Greg Miller Visterra
Brad Prosek Constellation Pharmaceuticals
Tom Needham Broadview Ventures, Inc.
Kleem Chaudhary Biogen
Paul Conrad Bluebird Bio
Catherine Thut Novartis Institutes for BioMedical Research
Ryan Brady Evotec
Bonnie Fendrock Cyta Therapeutics
Brad Carver SynDevRx
William Kuziel Daiichi Sankyo
Joyce Lonergan Mellitus
Adam Muzikant Flexion Therapeutics
Eric Elenko PureTech Ventures
Jonathan Behr Dementia Discovery Fund
David Hirsch Longitude Capital
Derek Bowen Blackfynn
Kathryn Gregory Seneb BioSciences, Inc.
Dora Mitchell Carisma Therapeutics Inc.
Heather Rose Thomas Jefferson University
Daniella Kranjac GE Healthcare Enterprise Solutions
Lillian Chiang FORGE Life Science
Barbara Fox Tilos Therapeutics
John Fletcher Fletcher Spaght Ventures
Steven Tregay FORMA Therapeutics
Ed Mascioli EMMD LLC
Arthur Hiller Antyllus Therapeutics
Oren Gilad Atrin Pharmaceuticals
Jim Weissman Dicerna
Guangtao Zhang Eleison Pharma
Michael Pine Aralez Pharmaceuticals
Scott Edwards SciFluor Life Sciences
Guy Fish Fletcher Spaght
Albert Robichaud Sage Therapeutics
Rob Sterling Ichor Therapeutics
Derek Lee Athyrium Capital
Niranjan Sardesai Geneos Therapeutics, Inc.
Helen Ho Blueprint Medicines
Martin Phillips Opsidio
Jeffrey Haines GlaxoSmithKline
Jim Lewis Personal Genome Diagnostics
Tania Dimitrova Pfizer
Ying Tam Mindful Scientific
Douglas Fisher InterWest Partners
Christopher de Souza Broadview Ventures
Chris Flores Janssen
Kuldeep Neote Eli Lilly
Paul Radspinner FluGen Inc
Michael Boretti Epizyme
Susan Drexler Ocugen
Kristi Sarno Pfenex
Kumar Bhargava Serentrix
Sundeep Dugar Sphaera Pharma
Michael Elliott J&J
Catherine Abbadie Sunovion
Minji Kim Jounce
TROY NORRIS Valamont Advisors
Manohar Katakam Sterotherapeutics LLC
John Tagliamonte WntRx
Joseph Zack Excalivir Diagnostics
Ramani Varanasi X-Biotix Therapeutics, Inc.
John Delyani Tmunity
Tariq Kassum Obsidian
Gwen Melincoff Gemini Advisors LLC
Jeffrey Moore MP Healthcare Venture Management
Nick DeLong Locust Walk
Maria Maccecchini QR Pharma
Peter Loftus The Wall Street Journal
Margie McGlynn Vertex, Amicus Therapeutics, Orphan Technologies
Thomas Hofmann Aumapharma
Christian Suojanen Bioseed Capital
Georg Nebgen Vivant Holdings
Rich Howlett Keros Therapeutics
Bob Palladino Bionevia LLC
Catherine Sohn Jazz Pharmaceuticals
Cyndi Green Pfizer
Lew Bender Intensity Therapeutics
Peter Leonardi OmniCyte
Diyong Xu OrbiMed Advisors
Sandip Agarwala Longitude Capital
Alan Roemer Roivant Sciences
Jerry Jabbour Matinas BioPharma
Bruce Goldsmith Lycera
Tom Hallam Leading BioSciences
Mona Ashiya OrbiMed
Yulii Bogatyrenko ATEM Capital
David Gould Actinium Pharmaceuticals
Lizabeth Leveille Merck
Mark Strobeck Egalet Corporation
Eric Nelson Fannin Innovation Studio
peter rock Etiometry Inc.
Ailis Tweed-Kent Cocoon Biotech
Adam McNulty Chiesi Group
Walter Kowtoniuk Third Rock Ventures
Walter Olesiak Remiges Ventures
Brian Hess LaunchPad Medical
Michael Dishowitz PCI Ventures, University of Pennsylvania
Giacomo Chiesi Chiesi Ventures
Amanda Cashin Illumina
Alexander Kraus Aquestive Therapeutics
Stephen Potter AGTC
Felipe Araujo Mount Sinai Innovation Partners (MSIP)
Ravi Rao TRex Bio
Gaye Bok Orionis Biosciences Inc.
Derek Yoon AJU IB Investment
Patrick Tricoli NANOBIOTIX US
Jay Knowles Partners Innovation Fund
Stephen Seiler Windgate Partners
Vicki Morgan viDA Therapeutics
Skip Irving Stemnion
Andrew Meadow International Cancer Impact Fund
Kathie Jordan Drexel University
Brandi Simpson Navigen
Joseph Simeone Merck
Kevin Chu F-Prime Capital Partners
Fumitaka Mori Remiges Ventures
Adam Gridley Histogenics
Tarik Soliman Extend Biosciences
Girish Aakalu Genocea Biosciences
Guillermo Rubio AMAG Pharmaceuticals
Bryan Stuart Yarra Therapeutics
James Harper Sonde Health
Jennifer Wheler Merriman Gardner Group
Jonathan Mandelbaum Accelerator Life Science Partners
Christopher Scannell InsideOutBio
Wamis Singhatat ActiveProtective
James Glasheen Technology Partners
Jonathan Kaufman Lipella Pharmaceuticals
Stephen Curtis MPM Capital
Brett Fleshman Chiesi USA
Will Robberts TesoRx Pharma
Michael Weickert Pacylex & Illumisonics
Jane Dancer F-star
Sheila DeWitt DeuteRx
Timothy Trost Chimerix
Anh Hoang Sofregen Medical
Dale Pfost Advent Life Sciences
Wen Luo Denovo Biopharma
Vishal Kapoor Ophthotech
Zach Rome Patagonia Pharmaceuticals
Tanya Shnaydman Santen
Mark Jelley OrbiMed
Gary Lee Amicus Therapeutics
Vladislav Sandler HemoGenyx LLC
Darren Braccia Lysosomal Therapeutics
Michael Wootton Vie Capital Partners LLC
Linda Brown BioNJ
Naoya Sato MP Healthcare Venture Management
Raymond Houck Aclipse Therapeutics
Stephen Popielarski Thermaquil, Inc.
John Brooks Arete Worldwide
Ole Mikkelsen Accuray
Derek Abel Longitude Capital
Charles Link NewLink Genetics
John Freshley ONL Therapeutics
Stacey Seltzer Aisling Capital
Michael Garrett EnBiotix
Robert Beardsley Galera Therapeutics
Anil Goyal MimiVax, LLC
Martin Cearnal CumberlandPharmaceuticals
Adam Bruce TikoMed
Bob Linke Embera NeuroTherapeutics
Peter Heinecke BioElectron Technology
David Collier Velocity Pharmaceutical Development
Koji Naito Mitsubishi Tanabe Pharma Corporation
Takuro Wakabayashi ASTEC
Doug Lee Samsung
Allen Ruszkowski CVAC Systems
Jeff Peterson Target Discovery & Veritomyx
John Gregg Balinbac Therapeutics
David Larwood Valley Fever Solutions
Bruce Beutel Dewpoint Therapeutics
Eric Stone Velano Vascular
TR Thirucote TesoRx Pharma
Bryant Fong Biomark Capital
Peter McWilliams Sanderling Ventures
Glenn Batchelder XyloCor Therapeutics
Mark Reynolds GeoVax
Christian Kopfli Chromocell
Beth Klein DuraThera
Michael Haller Denovo Biopharma
Joe Cunningham Sante Ventures
Lu Alleruzzo Immunophotonics
Jack Pasini Oligomerix
Amanda Kay Synlogic
Michael Paul Lineagen
Danguole Altman Vapogenix
Michael Detke Embera NeuroTherapeutics
DA Gros Imbria Pharma
Kollol Pal Pyramid Biosciences
Nail Edikhanov Klyss Biotech
Ashleigh Palmer Celimmune
Alan Mendelson Axiom venture partnekrs
Laurie Actman PCI
Sara Jane Demy Demy-Colton Life Science Advisors
Pete Garcia PDL BioPharma
Karen Boezi Broadway Angels
Ling Wong SLV
John Rodenrys Leading Biosciences
Deborah Chen D3 Drug Discovery and Development
Deborah Aghib NeuroZone
Katie Ellias JDRF T1d Fund
Gail Naughton Histogen
Shahzad Malik Advent Life Sciences
Carter Keller GigaGen
Elizabeth Aylward Seattle Children's Research Insitute
Michael Tippie TomegaVax, Inc.
Ping Guo The puguang investment holding group
Christopher Gibson Recursion Pharmaceuticals
Sara Radcliffe California Life Sciences Association
Nishant Rastogi New Rhein Healthcare
Randy Preston Esculon Inc.
Jayson Punwani Takeda Ventures
Scott Weiner
Mervyn Maze NeuroproteXeon
Sam Tetlow Grant Engine
Ivan Joseph Hsiri Therapeutics
Rodolphe Clerval ENTEROME
Jim Roach Pulmatrix
Brendan Luu EMD Serono Inc.
Matthew Hawryluk Gritstone Oncology
Kevin Mills Cyteir Therapeutics, Inc
Edwin Holland Cenoxsys, LLC/Cascade Biotechnology
Yury Kukushkin 4biocapital
Manav Mehta Gel4Med
Kate Rumrill NeoSync, Inc.
Gary Ruckelshaus Heritage Pharmaceuticals Inc.
Sanjay Mistry Janssen Pharmaceuticals
Joseph Vacca J. Vacca Consulting LLC
Georgia Mitsi Apptomics
John M Sorvillo ReForm Biologics
Charles Bernhardt SFA Therapeutics
Stefano Gulla Abcuro
Barbara Sosnowski Pfizer
Rosamond Deegan Bicycle Therapeutics
Maria Zlyhastseva BioBreak
Thomas Bliss TargaZyme
Armin Rump Otsuka Pharmaceutical
Kirsten Leute Osage University Partners
Craig Matturro 1315 Capital
Ben Cowen ImmunoMet Therapeutics
Scott Applebaum Context Therapeutics
Kevin Pong Anima Biotech
Alan Ginsberg Ironwood
anne altmeyer self
Dodzie Sogah Scholar Rock
Ram Aiyar Corvidia Therapeutics
Anthony Walsh BioInnovation Capital
Steve Carchedi Apexian Pharmaceuticals
Karen Krumeich Soligenix, Inc
Steve Axelrod G-Tech Medical, Inc.
Rashida Karmali Tactical Therapeutics, Inc
christophe degois Aimmune Therapeutics
Warren Czerniak Gedeon Richter USA
Bryan Lord Orthopedic Venture Partners
Christopher Holterhoff Amicus Therapeutics
Hiroshi Kawai Mitsubishi Tanabe Pharma Holdings America Inc.,
Arun Swaminathan Lynkogen Inc.
John Holaday ExoCyte Therapeutics
David Parkinson Essa Pharmaceuticals Inc
Lisa McKerracher BioAxone Biosciences Inc.
William Korinek Astrocyte Pharmaceuticals
Shobha Parthasarathi Harrington Discovery Institute
James Manuso Talfinium Investments
Kayvon Pourmirzaie Nasseo
MELDA UZBIL Variant Pharmaceuticals
Linda Hogan LLH Associates, LLC
Matt Devalaraja Corvidia Therapeutics, Inc
Wendy Nelson Boston Biotech Forum
Kaveh Milaninia Multerra Bio
Bradley Everson HepQuant
Mark Wilson MatriSys Bioscience
Rodney Altman Spindletop Capital
Cornelius Diamond Prediction BioSciences
Mukilan Mohan INanoBio Inc.
Bharath Takulapalli INanoBio Inc
John nolan WBB Securities - Asset Management
Christer Rosen Jupiter Orphan Therapeutics
Anthony Robinson Barclay Consulting
Carl Belczynski MICO Innovations, LLC
Eckhard Niemeier Pieris Pharmaceuticals GmbH
Daniel Seto SternAegis Ventures
Shawn Marcell ReadCoor
Komal Joshi Jounce Therapeutics
Anders Wiklund Wiklund International
Johnathon Anderson Somos Therapeutics
Shadi Saberi iSono Health
Erik Gentalen Intabio
William Altman CorInnova, Inc.
jim datin BioAgilytix
David Madden Mellitus LLC
Norbert Prenzel Sotio
Lisa Placanica Mount SInai Innovation Partners
Stephen Lensky EpimAb Biotherapeutics
Avina Sun OceanIQ Capital
Robb Lawrence TLC Therapeutics
Dan Brims Wolfswood Partners
Sam Assmann California Life Sciences Association
Kristina Rinker KRS BioPharma
Marshall Hayward Jupiter Orphan Therapeutics
Kia Motesharei EMD Serono
Matthew Schiller EMD Serono
Michael Van Zandt ARC Institution
Larry Cai Fosun
Christopher Hanson Grant Park Ventures
Kousuke Nakata Kissei Pharmaceutical Co., Ltd.
Katsuyoshi Akiyama Kissei Pharmaceutical Co., Ltd.
Ashley Nagle Domain Therapeutics
Matthew De Silva Notable Labs
Francisco Salva Complexa
Sukaina Alarakhia Moore Venture Partners
Simon Jones Regenacy Pharmaceuticals LLC
Thomas Farb-Horch Thrive Bioscience, Inc.
Raj Mohanty FemtoDx
Stephane Richard CureMatch Inc
Jason Ruth 5AM Ventures
Kathryn McCabe Eli Lilly
Nevin M. Summers MIT Synthetic Biology Center
Benjamin Sigel Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Omid Akhavan Anthro Ventures
Laura Tadvalkar MP Healthcare Venture Management
Kerrie Brady Cetrexion Therapeutics
Melissa Sherman MOBILion Systems Inc.
Ben Dake RA Capital
Marissa Fayer HERHealthEQ
Ramon Salsas Escat University of Pennsylvania, Gene Therapy Program
Arkesh Mehta OncoBindi Therapeutics
John Osborn Egalet Corporation
Joff Masukawa Diligentia
Thomas Leggett Axcella Health
Pedro Carrasco The One Health Company
Tom Penn MVP Capital Partners
Julien Pham Genprex
Reza Mazhari Novartis Institutes for BioMedical Research
Sophie Chapelle Scipher Medicine
J. Christopher LiPuma Fortress Investment Group
Rachael Hagan NephroDI Therapeutics, Inc.
Anna French Qiming Venture US
Rosy Hu Partners Innovation Fund
Laszlo Kiss Pfizer
Isabella Zhang JDRF T1D Fund
James Brauch Keryx Biopharmaceuticals
William Taylor Protalix Biotherapeutics
James Jogerst Berg Health
Adam Buckley VBI Vaccines Inc
Kim Seth Repare Therapeutics
Christine Brennan MRL Ventures Fund
Melissa Epperly PsiOxus
Kathryn McAllister Merck
Steve Trusko Teva Pharmaceuticals
Fred Chereau LogicBio
Tom Wilton LogicBio
Suresh Borsadia SHINKEI Therapeutics
Seiji Nakano Asahi Kasei - Healthcare
John Parker Springhood Ventures
Kyle Dempsey MVM Partners
Joanne Hackett Genomics England
Tom McCarthy Grey Wolf Therapeutics Ltd
Peter Joyce Grey Wolf Therapeutics
Mike Westby Centauri Therapeutics Ltd
Steven Harris Circassia
Enda Gribbon Atelix Ltd
Paul van der Horst Galapagos
Frank Haluska BioCanCell
Bruce Cohen Xeraya Life Capital
Graham Griffiths Vaccitech Ltd
Hayato Watanabe Eight Roads Ventures Japan
Manfred Horst Biophytis
Sanjay Zaveri Strongbridge Bio
Michael Scherz Metys Pharmaceuticals AG
Stephanie Oestreich Evotec
Alex Chang Helsinn Therapeutics US
Alex Zisson H.I.G. Capital
Winston Kung PMV Pharma
Evan Melrose Spindletop Capital
Brittany Berry-Pusey Avenda Health
James Barlow Geneos Therapeutics
Ronald Alfa Recursion Pharma
Matthew Kinn Recursion Pharmaceuticals
Andrew Gengos AOBiome
Al Altomari AGile Therapeutics, Inc.
Pamela Contag BioEclipse Therapeutics
Francisco Leon Provention
Richard Becker Levolta Pharmaceuticals
JD Finley Leading BioSciences, Inc.
Michael Dawson Leading Biosciences
Ronald Martell Indapta
Clifford Stocks OncoResponse, Inc.
Rachel Dreilinger NeuraMedica
Scott Coiante Agile Therapeutics
Margaret Hsiao Harvest moon pharma
Kazuhiko KATO ASKA pharma
Yogesh Bahl Bahl Partners
Raksha Shah Obsidio Therapeutics, Inc.
Yoshiaki Kato Kissei America Inc.
Masaya Etoh Asahi Kasei Pharma Corp
Amanda Gett-Chaperot Seventure
miwa toyoda JAFCO Co., Ltd.
Claudio Rumazza Innogest Capital
Dawn Bir REATA Pharmaceuticals
Randy Berholtz Mesa Verde Venture Partners
Aaron Schuchart Aeglea BioTherapeutics
Caroline H. Ko Northwestern University
Navin Govind Aventyn, Inc
Carey Ng Mesa Verde Venture Partners
Paul Jaminet Angiex Inc
Christoph Pittius, Ph.D. City of Hope
Sheldon Ng Locust Walk
Patric Nelson Esperion
Tae Hoon Kim Aju Pharm
Mary Rozenman Aimmune Therapeutics, Inc.
Sumit Jamuar GLOBAL GENE CORP
Brett Malone Flagship Biosciences
Stanley Kim WinSanTor
Steve King Trek
Douglas Kawahara Elex Biotech
Brian Finrow Lumen Bioscience, Inc.
Anton Neschadim ImmunoBiochem Corporation
david berry MD Leading BioSciences
Irena Barbulovic-Nad Quthero Inc.
James Forte Fairwater Marketing Strategies
Leslie Morgan OBE DL Durbin
Selin Kurnaz Massive Bio
Pascal Nigen Alpha Bronze
yoichiro miwa mitsui global investment
Lora Feng Hongjing Capital
Daniel Dudley Infinite Arthroscopy, Inc.
Piers Ingram Hummingbird Bioscience
MSB02 Masters Northwestern, Feinberg School of Medicine
Gabriele Grecchi Silk Biomaterials
Prasun Mishra Agility Pharmaceuticals
Doug Thiede New York City Economic Development Corporation
Mark Lewis NanoValent Pharmaceuticals Inc.
Noel Jee Illumina Ventures
Greg Kading IM Therapeutics
Dusan Perovic Two Sigma Ventures
Fei Jin DrugCendR Inc.
Leonide Saad Alkeus Pharmaceuticals
Josephine Harada 10x Genomics
James Zanewicz Tulane University School of Medicine
Staci Kearney Flagship Biosciences
Sathya Elumalai Multisensor Diagnostics
Ravi Kiron EMD Serono
Lena Cheng, MD Freenome
Fred Turner TL Biolabs
Timothy Enns NanoValent Pharmaceuticals, Inc.
Adam Rubenstein Articulus Bio
Tim Luker Eli Lilly
Keun Lee iProgen Biotech Inc.
Hamza Sheikh Syno Capital
Bernhard Guenther Novaliq Inc.
XQ Lin Carmentix
Luba Greenwood Google
Benjamin Kreitman Broadview Ventures
Tiffany Yu F-Prime Capital
Mike Luther Bantam Pharmaceutical, LLC
Thomas Lyons Marinus Pharmaceuticals
Mahesh Narayanan PepVax, Inc.
Baruch Harris Metera
JS CLEIFTIE erytech pharma
Christopher Gagliardi Sanofi Ventures
Thomas Kim EpiVario Inc.
Melissa McCracken Third Rock Ventures
Michael Egholm Danaher Life Sciences
Geoff Whitehead Ensign Peak Advisors
Laura Lane Aston Particle Technologies
Kevin Cheng MVM Partners LLP
Clark Cahoon Utah Governor's Office of Economic Development
Chris Tihansky University of Utah
Claire Mazumdar Third Rock Ventures
Niva Almaula Advanced Acceelerator Applications
Juan Garcia BioSeed Capital
Björn Walse SARomics Biostructures AB
Tim Dyer Addex Therapeutics
Chris Seitz Excel Venture Management
James Lovett Myoderm
Barbara Araneo USTAR
Kelly Beck Ocugen, Inc.
Sven Erickson Isofol Medical AB
Uciane Scarlett Atlas Venture
Anders Kristensson Tikomed AB
Alison Fenney Mount Sinai Innovation Partners
Hugo Beekman AJU IB
Loic VINCENT Takeda
Samuel Murphy Salubris Pharma
Seiji Hirasaki OriCiro Genomics
Hitoshi Shiomi Momotaro-Gene Inc
Tetsuo Takayama TAISHO PHARMACEUTICAL CO., LTD.
Evan Gibson Vir Biotechnology, Inc.
Lance Ostrom Roche
Dan Robinson OS Fund
Kevin Lynch Recursion Pharmaceuticals
Mark de Groot Pattern Pharma
Scott Robinson MicroQuin
Jamie Kasuboski Boehringer Ingelheim Venture Fund
Laurie Halloran Halloran Consulting Group
Markus Renschler Cyteir Therapeutics
Yossuf Albanawi Pilleve
Rajeev Chillakuru Elstar Therapeutics, Inc
Jaideep Dudani Relay Tx
Adam Friedman Vivid Biosciences
Debbie Lin Boehringer Ingelheim
Laura Maxon MOBILion Systems
Gregory Muir 1315 Capital
Frederic Sweeney Northern Biologics
Meghan Wood CureDuchenne
Ross Castillo JDRF T1D Fund
Brooke Paige Pear Therapeutics
Nikola Trbovic Pfizer
Philip Gotwals Novartis
Michael Woo Novartis
Lubor Gaal Locust Walk
stephen hurly Sesen Bio
Todd Woodworth BioInovation Capital
Graeme Bell Tmunity Therapeutics Inc.
Darren Pitt VisusNano
David Harper Evolution Biotechnologies
alex leech CamPhos Therapeutics
Christopher Primiano Karyopharm Therapeutics
Karolina Zapadka Babraham Bioscience Technologies Ltd
Antonio Alessandrino Silk Biomaterials
Edward Kliphuis M Ventures
Christine Bunt Verseau Therapeutics
Rick Hoyt Mallinckrodt Pharmaceuticals
Sara Remus Halloran Consulting Group
john chisholm Genomics England
Alex Aliper Insilico Medicine
Martin Tolar Alzheon Inc.
Mankit Law Pappas Capital
Darren Link TorpedoDx
Klaus Wilgenbus Allecra Therapeutics GmbH
Ella Korets-Smith Antibe Therapeutics
Hitoshi Ono Remiges
Stephen Marcus Cantex Pharmaceuticals, Inc.
Peter Hanson Centrexion Therapeutics
Sumit k Mody Health Passion Fund
Kent Pryor ZZ Biotech
Yolanda Chong Recursion
Imran Babar Cydan
Lorenzo Pellegrini Palladio Biosciences
James Garner Kazia Therapeutics Limited
Toby Wilson Waterworth Atlantic Healthcare plc
Crystal Nyitray Encellin
Luis Aguilar Advantagene
barry ticho Stoke Therapeutics
Daniel Rippy Lantheus Medical Imaging
Michael Derby Castle Creek Pharma
YOUNG Moon BL&H USA
Hugo Peris Spiral Therapeutics Inc
Marc Gleeson Azura Ophthalmics Limited
Liz Bhatt Achaogen
Jim McDonnell Kenzen
Vlad Coric Biohaven Pharmaceuticals
Greg Archambeau Revalesio Corporation
Christian Pangratz sterna biologicals gmbh & co. kg
Leah Sibener 3t Biosciences
Durga Bobba SutroVax, Inc
Mahmood Panjwani Artiman Ventures
Thomas Smith BioDelivery Sciences
Jigar Raythatha Constellation Pharmaceuticals, Inc.
Ray Krauss Camras Vision
Rod Hafner Circassia
Tatiana Novobrantseva Verseau Therapeutics
Josh Schafer Mallinckrodt
Harri Jarvelainen DrugCendR Inc.
Michelle Ho 5AM Ventures
John Alam EIP Pharma
Dean Schauer Confluent Medical
Doug Hatran Hydra Vascular
Joshua Reed Aldeyra Therapeutics
Armando Anido Zynerba Pharmaceuticals
Peter Goettel Berlin Cures
curtis hecht Calithera
Eran Rosines Rosivo Inc
Naoaki Shibata ASKA Pharmaceutical Co., Ltd.
Jennifer Beachell Beachell Consulting, LLC
Guy Spigelman aMoon Fund
Joanna Gould VisusNano
Yaniv Bejerano Innate Biotherapeutics
Elaine Haynes KaloCyte, Inc.
Andreas Muehler Immunic AG
TIMM CROWDER SPYRYX BIOSCIENCES
Jerome Boyd-Kirkup Hummingbird Bioscience Inc.
Bernard Rudnick Virion Therapeutics, LLC
Lynn Durham STALICLA SA
Kevin Hacker Bio-Affinity Sciences
Blair Lapointe Merck & Co.
Nick Mark Intermountain Healthcare
Yasuo Takehana KISSEI Pharmaceutical
Eliza Adams Redpoint Ventures
Andy Luber Virion Therapeutics
Jerry Chen Mucker Capital
Karen Drexler Sandstone Diagnostics
Lee Bowman Mediphage Bioceuticals
Ana Alves CortexXus
Kevin Cameron Ionetix
Andy Lee Vincere Biosciences, Inc
onne ganel DTx Pharma
sara nunez-garcia Roivant Sciences
Steven Nichtberger Cabaletta Bio
Bala Raja Luminostics
Rick Birkmeyer Tange
Jeannie Kim Acer Therapeutics
Colin Magowan Virion Therapeutics
Ritankar Das Hessian Pharmaceuticals
John Temperato Atlantic Healthcare plc
Walter Martucci Akili Interactive
Wolfgang Troebs Roche Diagnostics
Kevin Xie Scientific Protein Labs
Ali Siam Celmatix
Brian Glaister Octavia Health
Cody Simmons DermaSensor Inc
Cristiane Benvenuto DermaSensor Inc
Walter David City of Hope
Tomas Hode Immunophotonics, Inc.
Remis Bistras ThermoPharma
Scott Woodward Ventac Partners
Itzhak Avneri NewUro B.V.
Lukas Pieter NAVICAN Genomics Inc.
Zuzanna Brzosko Sixfold Bioscience
Brian Harris MedRhythms, Inc.
Kris Kupumbati Onecrea Medical, Inc.
Dmitry Kaminsky DKV
Tina Larson Recursion Pharmaceuticals
Vera Hoffman Reveal Pharmaceuticals
Lior Avneri NewUro
kan chen qiming venture partners
Chuanbo Xu Vienomics Corp.
Lily Li Winnermax Capital Inc.
Wen Dombrowski CATALAIZE
Nardo Manaloto CATALAIZE
haikun shi Teclison limited
Valerie Photos Iaso Ventures
Ray Lee Teclison Limited
Dr Juliet Singh Strategic Swiss Partners
Hsueh-Yen Ku Foxconn (Healthcare Group )
Robert Crane Verseau Therapeutics
Marvin Yu MS2 Array LLC
Dan Barber Aquestive
Anil Bhushan Deciduous Therapeutics
Maximilian Schmid Roche
Todd Krueger AOBiome Therapeutics
James Welsh MolecularMatch, Inc.
Don Corley MolecularMatch, Inc.
Arthur Suckow DTx Pharma
Eric Pulaski MolecularMatch, Inc.
Jennifer McCaney UCLA Biodesign
David Garrett Hessian Pharmaceuticals
GRACE WEI Encellin
Anders Rabbe Isofol Medical
Howard Carolan CoapTech
Daniel Jacobs Pathway Bioventures
Rich Yang SHARP Life Science USA
charles Ryan Neurotrope, INC
Arthur Chen 618 Ventures
Mina Sooch Ocuphire Pharma
Daniel Alkon Neurotrope, Inc.
Ruedi Stoffel Roche Diagnostics
Carlo Yuvienco NYCEDC
Jonathan Mow PhaseBio Pharmaceuticals
Joe Romano ZZ Biotech
Kostas Alevizopoulos Avexxin
Dede Willis Ventac Partners
Michel Dahan Akebia Therapeutics
Alok Nandan Emergent Ventures
Nima Emami Avail Bio
Jeff Stevens Alexandria LaunchLabs

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com